PO.PS01.09 · 人群科学

脂肪肝指数及AST/ALT比值用于预测低危韩国男性肝细胞癌:HEXA-G队列研究结果

Fatty liver index and AST/ALT ratio for hepatocellular carcinoma prediction in low-risk Korean men: Results from the HEXA-G cohort

编号 7585 展板 5 时间 4/22 09:00–12:00 区域 Section 35 主讲 So-Yoon Lee, BA;MD;MS
分会场 Risk Prediction Modeling, Screening, Early Detection, and Preneoplastic and Tumor Markers
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

So Yoon Lee1, Hyobin Lee1, Sukhong Min1, Sinyoung Cho2, Jeongheon Kim1, Ji-Yeob Choi3, Daehee Kang4

1Seoul National University, Seoul, Korea, Republic of,2Seoul National University Hospital, Seoul, Korea, Republic of,3Assistant Professor, Seoul National Univ. College of Medicine, Seoul, Korea, Republic of,4Dean, Professor, Dept. of Molecular Medicine And Biopharmaceutical Sciences, Seoul National University, Seoul, Korea, Republic of

摘要 Abstract

中文摘要
背景:脂肪肝指数(FLI,一种源自BMI、腰围、甘油三酯及GGT的脂肪变性指数)及AST/ALT(De Ritis)比值在低危亚洲人群中对肝细胞癌(HCC)风险的预后效用尚未明确界定。我们在一个大型韩国队列中评估了它们的独立及增量预测价值。 方法:我们分析了来自Health Examinees-Gem(HEXA-G)队列(2004-2013年)的43,981例韩国男性(376例HCC病例)。通过排除糖尿病或慢性肝炎个体,定义了一个低危亚队列(n = 39,033)。多变量Cox模型在校正人口学、生活方式、社会经济及代谢因素后,评估了与对数转换后的FLI及AST/ALT比值的关联。增量预测价值采用似然比检验(LRT)、C统计量变化及贝叶斯信息准则(BIC)进行评估。使用惩罚回归的敏感性分析得出了相似的结果。 结果:在单变量分析中,AST/ALT比值与HCC存在粗关联,而FLI则无。校正后,这一模式发生逆转:AST/ALT比值变得无预测性——这与年龄、饮酒、吸烟及代谢因素的混杂效应一致——而log(FLI)在低危亚队列中成为一个适度的独立预测因子(校正HR 1.08;95% CI,1.01-1.16;p = 0.04)。区分度改善甚微(C统计量从0.715升至0.719),且传统FLI分类未能对风险进行分层。在完整队列中,log(FLI)仍与HCC独立相关(校正HR 1.11;95% CI,1.03-1.20;p = 0.009),并适度改善了模型拟合(LRT p = 0.011),但未能有意义地改善区分度(C统计量从0.795升至0.797)。De Ritis比值在任何模型中均未增加独立或增量价值。 结论:在低危及混合风险的韩国男性中,FLI在校正后仍是HCC的独立预测因子,尽管效应量适度。相反,AST/ALT比值在考虑人口学、生活方式及代谢混杂因素后丧失了所有预后价值。粗关联与校正关联之间的逆转凸显了AST/ALT存在显著混杂,以及FLI存在一个微小的、与代谢相关的信号。总体而言,这些发现表明FLI在低危环境中提供了一定的独立信息,但HCC风险预测的实质性改善将需要更稳健的生物标志物。
查看英文原文 English abstract
Background: The prognostic utility of the fatty liver index (FLI, a steatosis index derived from BMI, waist circumference, triglycerides, and GGT) and AST/ALT (De Ritis) ratio for hepatocellular carcinoma (HCC) risk in low-risk Asian populations is not well defined. We evaluated their independent and incremental predictive value in a large Korean cohort. Methods: We analyzed 43,981 Korean men (376 HCC cases) from the Health Examinees-Gem (HEXA-G) cohort (2004-2013). A low-risk subcohort (n = 39,033) was defined by excluding individuals with diabetes or chronic hepatitis. Multivariable Cox models assessed associations with log-transformed FLI and the AST/ALT ratio after adjusting for demographic, lifestyle, socioeconomic, and metabolic factors. Incremental predictive value was evaluated using likelihood ratio tests (LRTs), changes in C-statistics, and Bayesian Information Criterion (BIC). Sensitivity analyses using penalized regression produced similar results. Results: In univariable analyses, the AST/ALT ratio showed crude associations with HCC, whereas FLI did not. After adjustment, this pattern reversed: the AST/ALT ratio became non-predictive-consistent with confounding by age, alcohol consumption, smoking, and metabolic factors-while log(FLI) emerged as a modest independent predictor in the low-risk subcohort (adjusted HR 1.08; 95% CI, 1.01-1.16; p = 0.04). Discrimination improved minimally (C-statistic 0.715 to 0.719), and conventional FLI categories failed to stratify risk. In the full cohort, log(FLI) remained independently associated with HCC (adjusted HR 1.11; 95% CI, 1.03-1.20; p = 0.009) and modestly improved model fit (LRT p = 0.011) without meaningfully improving discrimination (C-statistic 0.795 to 0.797). The De Ritis ratio added no independent or incremental value in any model. Conclusions: Across low-risk and mixed-risk Korean men, FLI remained an independent predictor of HCC after adjustment, although the effect size was modest. In contrast, the AST/ALT ratio lost all prognostic value after accounting for demographic, lifestyle, and metabolic confounding. The reversal of crude versus adjusted associations underscores substantial confounding for AST/ALT and a small, metabolically related signal for FLI. Overall, these findings highlight that FLI provides some independent information in low-risk settings, but substantial improvement in HCC risk prediction will require more robust biomarkers.
利益披露 Disclosure
S. Lee, None.. J. Kim, None.

← 返回 AACR 2026 检索